Heart Failure Online 2022 On-demand
Published: 09 May 2022
Session 1.3 - Patient Case Revisited: Transitioning Care and Monitoring Technology
- Session 1:1 - Patient Case: The Complex Patient
- Session 1.2 - Practical Theory and Hot Topics
- Session 1.3 - Patient Case Revisited: Transitioning Care and Monitoring Technology
- Session 1.4 - Practical Theory and Hot Topics
- Symposium - The 2022 ACC Heart Failure Guidelines: What Do They Mean for Your Practice?
Heart Failure Online (HFO) is a new innovative virtual event, that brings together a leading international faculty to create a rich, interactive experience to best inform the global heart failure community of the latest developments and advances in clinical practice.
With patient management and outcomes at its core, Course Director Prof Andrew Coats (President of the Heart Failure Association and Professor of Cardiology, University of Warwick, UK) leads an interactive programme of discussion, opinion and case studies focusing on the patient journey.
Note, the live version of this session was CME accredited; this on-demand version is not.
Key Learning Objectives
Following the activities, participants will be able to:
- Select foundational and advanced management strategies in complex patients
- Discuss the validity of using ejection fraction to determine optimal treatment strategies
- Assess the likely impact of health technology on future practice
- Identify the underlying causes of heart failure
- Select appropriate interventional and device-based treatments for treating underlying causes of heart failure
- Assess the impact of the multidisciplinary team on heart failure outcomes
- Discuss the importance of using quality of life and patient self-assessed measures relative to hard clinical end points
- Heart Failure Specialists
- General Cardiologists
- General Practitioners (GPs)
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Day One: Individualising Treatment
Day Two: Complex Phenotypes and Advanced Treatment
Day Three: Beyond Foundational Management
Ileana L Piña
Dr Ileana L Pina is Professor at the Department of Medicine (Cardiology) and Professor in the Department of Epidemiology and Population Health at Montefiore Einstein Center for Heart and Vascular Care, US.
Dr Piña has a particular research and clinical interest in rehabilitation of heart disease in patients with heart failure. She completed a NHLBI HF ACTION trial and is in the process of examining recovery after exercise which could be translated to an additional parameter that may better predict prognosis of outcomes. In addition, there was a R21 to NHLBI to examine Vitamin D levels as another predictor from the HF ACTION database.
Dr Ileana L Pina is an Editorial Board member of Cardiac Failure Review.
Prof Philipp Lurz is Deputy Head of the Department at Heart Center Leipzig, Germany, a position he has held since 2018. Previously, Prof Lurz was a Clinical Research Fellow at Great Ormond Street Hospital for Children NHS Foundation Trust. He completed his education at the University of Leipzig, and is a member of the German Society of Cardiology. Prof Lurz is widely published in leading international peer-reviewed journals.
Dr Loreena Hill is a senior lecturer at the School of Nursing and Midwifery, Queens University in Belfast, UK. Dr Hill’s research focuses on the management of patients with chronic heart failure, specifically those in advanced stages. She leads a co-design European study to develop an innovative intervention to improve patient and family decision-making concerning Implantable Cardioverter Defibrillators within palliative care.
Dr Loreena Hill is an Editorial Board member of Cardiac Failure Review.
Harriette Van Spall
Associate Professor of Medicine, Director of E-Health and Virtual Care
Dr Harriette Van Spall is an Associate Professor of Medicine and cardiologist and serves as Director of E-Health at McMaster University, Canada. She completed her medical and postgraduate clinical training at the University of Toronto and earned a Master of Public Health degree at Harvard University, US. Dr Van Spall is a Canadian Institutes of Health Research-funded clinical trialist and researcher with a focus on heart failure, health services, and health disparities.
She has garnered more than $4 million in research funding, has won several research awards, and has published her work in high-impact medical journals. She is an invited speaker, media correspondent, and editorial board member active in peer review at several high-impact medications journals and grant funding agencies, including Canadian Institutes of Health Research and Heart and Stroke Foundation of Canada.
Dr Van Spall is an Editorial Board…